Lipocine To Present At M Vest / Maxim Conference And At The Lytham Partners Conference
Lipocine To Present At M Vest / Maxim Conference And At The Lytham Partners Conference News provided by Share this article Share this article SALT LAKE CITY, March 11, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Company will present at the M Vest LLC and Maxim Group LLC Emerging Growth Virtual Conference and the Lytham Partners Spring 2021 Investor Conference. Both conferences will be held virtually. Presentation details are below. M Vest LLC and Maxim Group Emerging Grow...